Veeva Systems Inc. (VEEV)

$199.09

-1.43

(-0.71%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Veeva Systems Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 526.32M → 630.61M (in $), with an average increase of 5.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 111.62M → 147.39M (in $), with an average increase of 12.9% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 47.1% return, outperforming this stock by 33.8%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 3.8% return, outperforming this stock by 33.1%

Performance

  • $194.83
    $199.42
    $199.09
    downward going graph

    2.14%

    Downside

    Day's Volatility :2.3%

    Upside

    0.17%

    downward going graph
  • $160.21
    $236.90
    $199.09
    downward going graph

    19.53%

    Downside

    52 Weeks Volatility :32.37%

    Upside

    15.96%

    downward going graph

Returns

PeriodVeeva Systems Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-3.69%
1.1%
0.0%
6 Months
2.95%
12.5%
0.0%
1 Year
12.12%
6.9%
2.2%
3 Years
-29.27%
14.3%
-23.0%

Highlights

Market Capitalization
32.4B
Book Value
$28.8
Earnings Per Share (EPS)
3.22
PE Ratio
62.45
PEG Ratio
1.35
Wall Street Target Price
241.47
Profit Margin
22.24%
Operating Margin TTM
21.45%
Return On Assets TTM
5.01%
Return On Equity TTM
12.58%
Revenue TTM
2.4B
Revenue Per Share TTM
14.72
Quarterly Revenue Growth YOY
11.899999999999999%
Gross Profit TTM
1.5B
EBITDA
462.0M
Diluted Eps TTM
3.22
Quarterly Earnings Growth YOY
-0.23
EPS Estimate Current Year
4.76
EPS Estimate Next Year
5.57
EPS Estimate Current Quarter
1.3
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    66%Buy
    30%Hold
    3%Sell
Based on 33 Wall street analysts offering stock ratings for Veeva Systems Inc.(by analysts ranked 0 to 5 stars)
Based on 33 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
22
20
22
Hold
10
10
11
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 21.29%

Current $199.09
Target $241.47

Company Financials

FY19Y/Y Change
Revenue
862.2M
↑ 25.77%
Net Income
229.8M
↑ 61.89%
Net Profit Margin
26.66%
↑ 5.95%
FY20Y/Y Change
Revenue
1.1B
↑ 28.05%
Net Income
301.1M
↑ 31.02%
Net Profit Margin
27.27%
↑ 0.61%
FY21Y/Y Change
Revenue
1.5B
↑ 32.7%
Net Income
380.0M
↑ 26.2%
Net Profit Margin
25.94%
↓ 1.33%
FY22Y/Y Change
Revenue
1.9B
↑ 26.33%
Net Income
427.4M
↑ 12.47%
Net Profit Margin
23.09%
↓ 2.85%
FY23Y/Y Change
Revenue
2.2B
↑ 16.44%
Net Income
487.7M
↑ 14.11%
Net Profit Margin
22.63%
↓ 0.46%
FY24Y/Y Change
Revenue
2.4B
↑ 9.68%
Net Income
525.7M
↑ 7.79%
Net Profit Margin
22.24%
↓ 0.39%
Q4 FY22Q/Q Change
Revenue
552.4M
↑ 3.39%
Net Income
108.5M
↑ 19.71%
Net Profit Margin
19.64%
↑ 2.68%
Q1 FY23Q/Q Change
Revenue
563.4M
↑ 2.0%
Net Income
188.5M
↑ 73.83%
Net Profit Margin
33.46%
↑ 13.82%
Q2 FY23Q/Q Change
Revenue
526.3M
↓ 6.58%
Net Income
131.5M
↓ 30.24%
Net Profit Margin
24.99%
↓ 8.47%
Q3 FY23Q/Q Change
Revenue
590.2M
↑ 12.14%
Net Income
111.6M
↓ 15.13%
Net Profit Margin
18.91%
↓ 6.08%
Q4 FY23Q/Q Change
Revenue
616.5M
↑ 4.45%
Net Income
135.2M
↑ 21.08%
Net Profit Margin
21.92%
↑ 3.01%
Q1 FY24Q/Q Change
Revenue
630.6M
↑ 2.29%
Net Income
147.4M
↑ 9.06%
Net Profit Margin
23.37%
↑ 1.45%
FY19Y/Y Change
Total Assets
1.7B
↑ 37.76%
Total Liabilities
416.0M
↑ 26.46%
FY20Y/Y Change
Total Assets
2.3B
↑ 37.37%
Total Liabilities
606.2M
↑ 45.71%
FY21Y/Y Change
Total Assets
3.0B
↑ 34.08%
Total Liabilities
779.7M
↑ 28.63%
FY22Y/Y Change
Total Assets
3.8B
↑ 25.29%
Total Liabilities
904.8M
↑ 16.04%
FY23Y/Y Change
Total Assets
4.8B
↑ 25.88%
Total Liabilities
1.1B
↑ 20.25%
FY24Y/Y Change
Total Assets
5.9B
↑ 23.03%
Total Liabilities
1.3B
↑ 16.36%
Q4 FY22Q/Q Change
Total Assets
4.2B
↑ 1.61%
Total Liabilities
763.9M
↓ 12.46%
Q1 FY23Q/Q Change
Total Assets
4.8B
↑ 14.86%
Total Liabilities
1.1B
↑ 42.43%
Q2 FY23Q/Q Change
Total Assets
5.0B
↑ 4.56%
Total Liabilities
1.1B
↓ 0.71%
Q3 FY23Q/Q Change
Total Assets
5.2B
↑ 4.08%
Total Liabilities
1.1B
↓ 0.44%
Q4 FY23Q/Q Change
Total Assets
5.2B
↓ 0.05%
Total Liabilities
846.0M
↓ 21.34%
Q1 FY24Q/Q Change
Total Assets
5.9B
↑ 13.11%
Total Liabilities
1.3B
↑ 49.66%
FY19Y/Y Change
Operating Cash Flow
310.8M
↑ 32.54%
Investing Cash Flow
-103.9M
↓ 32.78%
Financing Cash Flow
25.9M
↑ 24.73%
FY20Y/Y Change
Operating Cash Flow
437.4M
↑ 40.71%
Investing Cash Flow
-516.9M
↑ 397.66%
Financing Cash Flow
10.0M
↓ 61.37%
FY21Y/Y Change
Operating Cash Flow
551.2M
↑ 26.04%
Investing Cash Flow
-333.6M
↓ 35.46%
Financing Cash Flow
33.8M
↑ 237.84%
FY22Y/Y Change
Operating Cash Flow
764.5M
↑ 38.68%
Investing Cash Flow
-346.2M
↑ 3.75%
Financing Cash Flow
-4.1M
↓ 112.24%
FY23Y/Y Change
Operating Cash Flow
780.5M
↑ 2.09%
Investing Cash Flow
-1.0B
↑ 191.11%
Financing Cash Flow
-19.4M
↑ 368.02%
Q4 FY22Q/Q Change
Operating Cash Flow
142.7M
↑ 52.76%
Investing Cash Flow
-405.7M
↑ 120.26%
Financing Cash Flow
-10.5M
↑ 33.73%
Q1 FY23Q/Q Change
Operating Cash Flow
63.3M
↓ 55.63%
Investing Cash Flow
-39.3M
↓ 90.32%
Financing Cash Flow
-2.2M
↓ 78.74%
Q2 FY23Q/Q Change
Operating Cash Flow
505.9M
↑ 699.29%
Investing Cash Flow
-297.4M
↑ 657.46%
Financing Cash Flow
-1.4M
↓ 37.88%
Q3 FY23Q/Q Change
Operating Cash Flow
265.0M
↓ 47.61%
Investing Cash Flow
-618.9M
↑ 108.12%
Financing Cash Flow
2.6M
↓ 285.13%
Q4 FY23Q/Q Change
Operating Cash Flow
82.6M
↓ 68.84%
Investing Cash Flow
-73.3M
↓ 88.15%
Financing Cash Flow
-6.9M
↓ 367.33%

Technicals Summary

Sell

Neutral

Buy

Veeva Systems Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Veeva Systems Inc.
Veeva Systems Inc.
-12.6%
2.95%
12.12%
-29.27%
46.25%
Solventum Corp
Solventum Corp
-8.05%
-8.05%
-8.05%
-8.05%
-8.05%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-1.77%
34.43%
7.87%
43.36%
43.36%
Healthequity Inc
Healthequity Inc
-0.35%
9.82%
47.13%
3.76%
9.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Veeva Systems Inc.
Veeva Systems Inc.
62.45
62.45
1.35
4.76
0.13
0.05
NA
28.8
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.44
28.44
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
124.8
124.8
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.4B
46.25%
62.45
22.24%
Solventum Corp
Solventum Corp
NA
$11.7B
-8.05%
NA
16.42%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.4B
43.36%
28.44
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
9.11%
124.8
5.57%

Institutional Holdings

  • Vanguard Group Inc

    8.16%

  • BlackRock Inc

    5.75%

  • AllianceBernstein L.P.

    4.18%

  • Artisan Partners Limited Partnership

    4.08%

  • T. Rowe Price Associates, Inc.

    3.60%

  • T. Rowe Price Investment Management,Inc.

    2.72%

Company Information

veeva systems inc. is a leader in cloud-based software for the global life sciences industry. committed to innovation, product excellence, and customer success, veeva has more than 300 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. veeva is headquartered in the san francisco bay area, with offices in europe, asia, and latin america. for more information, visit www.veeva.com.

Organization
Veeva Systems Inc.
Employees
7172
CEO
Mr. Peter P. Gassner
Industry
Packaged Software

Discover More

FAQs